Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone Furoate
Status:
Suspended
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The aims is to evaluate the efficacy and comparative isolation of the association Mometasone
furoate + Salicylic Acid and the substance isolated Mometasone furoate produced by the
Laboratory Glenmark Pharmaceuticals Ltd. in patients of both sexes, patients with plaque
psoriasis grade mild to moderate.